Open AccessA RANDOMIZED TRIAL COMPARING TACROLIMUS/ MYCOPHENOLATE MOFETIL (CELLCEPT) VERSUS TACROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM (MYFORTIC) IN FIRST RENAL TRANSPLANTS INDUCED WITH BOTH DACLIZUMAB AND THYMOGLOBULIN WITH STEROID AVOIDANCE.
Author(s) -
AUTHOR_ID
Publication year - 2006
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200607152-00751
Subject(s) - tacrolimus , daclizumab , medicine , mycophenolate , thymoglobulin , randomized controlled trial , pharmacology , urology , transplantation